{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:56:32Z","timestamp":1771026992605,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-06983-1","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:05:44Z","timestamp":1747753544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A retrospective analysis of vortioxetine utilization in children and adolescents with major depressive disorder in clinical practice"],"prefix":"10.1186","volume":"25","author":[{"given":"Xianmei","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keliang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Handi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"6","key":"6983_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):593\u2013602.","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"6983_CR2","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1469-7610.2006.01682.x","volume":"47","author":"E Jane Costello","year":"2006","unstructured":"Jane Costello E, Erkanli A, Angold A. Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry Allied Discip. 2006;47(12):1263\u201371.","journal-title":"J Child Psychol Psychiatry Allied Discip"},{"issue":"6","key":"6983_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/YCO.0000000000000749","volume":"34","author":"P Hazell","year":"2021","unstructured":"Hazell P. Updates in treatment of depression in children and adolescents. Curr Opin Psychiatry. 2021;34(6):593\u20139.","journal-title":"Curr Opin Psychiatry"},{"issue":"9783","key":"6983_CR4","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/S0140-6736(11)60512-6","volume":"377","author":"FM Gore","year":"2011","unstructured":"Gore FM, Bloem PJ, Patton GC, Ferguson J, Joseph V, Coffey C, et al. Global burden of disease in young people aged 10\u201324 years: a systematic analysis. Lancet (London England). 2011;377(9783):2093\u2013102.","journal-title":"Lancet (London England)"},{"issue":"10","key":"6983_CR5","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1176\/appi.ajp.2007.06101757","volume":"164","author":"S Zisook","year":"2007","unstructured":"Zisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, et al. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry. 2007;164(10):1539\u201346.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"6983_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/MOP.0b013e32833063e1","volume":"21","author":"SJ Cash","year":"2009","unstructured":"Cash SJ, Bridge JA. Epidemiology of youth suicide and suicidal behavior. Curr Opin Pediatr. 2009;21(5):613\u20139.","journal-title":"Curr Opin Pediatr"},{"issue":"5","key":"6983_CR7","first-page":"Cd013674","volume":"5","author":"SE Hetrick","year":"2021","unstructured":"Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, et al. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev. 2021;5(5):Cd013674.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"6983_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s40262-017-0612-7","volume":"57","author":"G Chen","year":"2018","unstructured":"Chen G, H\u00f8jer AM, Areberg J, Nomikos G. Vortioxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet. 2018;57(6):673\u201386.","journal-title":"Clin Pharmacokinet"},{"key":"6983_CR9","unstructured":"FDA. Specific requirements on content and format of labeling for human prescription drugs: revision of pediatric use subsection in the labeling: final rule. Fed Regist. 1994;59."},{"issue":"9","key":"6983_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.jaac.2022.01.004","volume":"61","author":"RL Findling","year":"2022","unstructured":"Findling RL, DelBello MP, Zuddas A, Emslie GJ, Ettrup A, Petersen ML, et al. Vortioxetine for major depressive disorder in adolescents: 12-week randomized, placebo-controlled, fluoxetine-referenced, fixed-dose study. J Am Acad Child Adolesc Psychiatry. 2022;61(9):1106\u2013e11181102.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"6983_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/0269881115581093","volume":"29","author":"A Cleare","year":"2015","unstructured":"Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015;29(5):459\u2013525.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"6983_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.31887\/DCNS.2016.18.4\/ncutler","volume":"18","author":"JJ Sramek","year":"2016","unstructured":"Sramek JJ, Murphy MF, Cutler NR. Sex differences in the psychopharmacological treatment of depression. Dialog Clin Neurosci. 2016;18(4):447\u201357.","journal-title":"Dialog Clin Neurosci"},{"issue":"4","key":"6983_CR13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/01.jcp.0000168879.03169.ce","volume":"25","author":"A Khan","year":"2005","unstructured":"Khan A, Brodhead AE, Schwartz KA, Kolts RL, Brown WA. Sex differences in antidepressant response in recent antidepressant clinical trials. J Clin Psychopharmacol. 2005;25(4):318\u201324.","journal-title":"J Clin Psychopharmacol"},{"issue":"1\u20133","key":"6983_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jad.2006.04.029","volume":"95","author":"C Berlanga","year":"2006","unstructured":"Berlanga C, Flores-Ramos M. Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of Citalopram and reboxetine. J Affect Disord. 2006;95(1\u20133):119\u201323.","journal-title":"J Affect Disord"},{"issue":"9","key":"6983_CR15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1176\/appi.ajp.157.9.1445","volume":"157","author":"SG Kornstein","year":"2000","unstructured":"Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry. 2000;157(9):1445\u201352.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"6983_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1176\/ajp.145.1.41","volume":"145","author":"E Frank","year":"1988","unstructured":"Frank E, Carpenter LL, Kupfer DJ. Sex differences in recurrent depression: are there any that are significant? Am J Psychiatry. 1988;145(1):41\u20135.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"6983_CR17","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1176\/appi.ajp.160.9.1643","volume":"160","author":"MG Hildebrandt","year":"2003","unstructured":"Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P. Are gender differences important for the clinical effects of antidepressants? Am J Psychiatry. 2003;160(9):1643\u201350.","journal-title":"Am J Psychiatry"},{"issue":"8","key":"6983_CR18","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1017\/S0033291703007918","volume":"33","author":"G Parker","year":"2003","unstructured":"Parker G, Parker K, Austin MP, Mitchell P, Brotchie H. Gender differences in response to differing antidepressant drug classes: two negative studies. Psychol Med. 2003;33(8):1473\u20137.","journal-title":"Psychol Med"},{"issue":"11","key":"6983_CR19","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1176\/appi.ajp.159.11.1848","volume":"159","author":"FM Quitkin","year":"2002","unstructured":"Quitkin FM, Stewart JW, McGrath PJ, Taylor BP, Tisminetzky MS, Petkova E, et al. Are there differences between women\u2019s and men\u2019s antidepressant responses? Am J Psychiatry. 2002;159(11):1848\u201354.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"6983_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00004850-200501000-00001","volume":"20","author":"C Thiels","year":"2005","unstructured":"Thiels C, Linden M, Grieger F, Leonard J. Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline. Int Clin Psychopharmacol. 2005;20(1):1\u20137.","journal-title":"Int Clin Psychopharmacol"},{"issue":"1\u20133","key":"6983_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jad.2006.02.010","volume":"93","author":"A Pinto-Meza","year":"2006","unstructured":"Pinto-Meza A, Usall J, Serrano-Blanco A, Su\u00e1rez D, Haro JM. Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference? J Affect Disord. 2006;93(1\u20133):53\u201360.","journal-title":"J Affect Disord"},{"issue":"1","key":"6983_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/cap.2017.0047","volume":"28","author":"RL Findling","year":"2018","unstructured":"Findling RL, Robb AS, DelBello MP, Huss M, McNamara NK, Sarkis EH, et al. A 6-month open-label extension study of vortioxetine in pediatric patients with depressive or anxiety disorders. J Child Adolesc Psychopharmacol. 2018;28(1):47\u201354.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"6983_CR23","doi-asserted-by":"publisher","first-page":"e1242","DOI":"10.1542\/peds.2010-3487","volume":"128","author":"J Dunne","year":"2011","unstructured":"Dunne J, Rodriguez WJ, Murphy MD, Beasley BN, Burckart GJ, Filie JD, et al. Extrapolation of adult data and other data in pediatric drug-development programs. Pediatrics. 2011;128(5):e1242\u20131249.","journal-title":"Pediatrics"},{"issue":"9","key":"6983_CR24","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jaac.2022.03.019","volume":"61","author":"KE Towbin","year":"2022","unstructured":"Towbin KE. Editorial: not the same as adults: vortioxetine in adolescents with major depression. J Am Acad Child Adolesc Psychiatry. 2022;61(9):1081\u20133.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10047","key":"6983_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","volume":"388","author":"A Cipriani","year":"2016","unstructured":"Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet (London England). 2016;388(10047):881\u201390.","journal-title":"Lancet (London England)"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06983-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06983-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06983-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:05:45Z","timestamp":1747753545000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06983-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6983"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06983-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"4 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. The study protocol was reviewed and approved by by the Ethics Committee of the Fourth People\u2019s Hospital of Chengdu. As the research involved minors but posed minimal risk and did not affect participants\u2019 rights or welfare, the Institutional Review Board granted a waiver of informed consent(Approval No: 2023-13). All necessary precautions were taken to ensure the privacy and confidentiality of the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"509"}}